4
Changes in Ownership
TherapeuticsMD, Inc. Filed Acc 0001209191-23-004871
Prin. Fin. and Acctg. Officer sold 1,309 shares at an average $5.34 ($6,988)
- Prin. Fin. and Acctg. Officer acquired 4,365 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Donegan Michael C · Prin. Fin. and Acctg. Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-23 | Exercise or conversion : show line 1 in the form | +380 | 4,934 | D | ||
| 2023-01-23 | Exercise or conversion : show line 2 in the form | +1,066 | 6,000 | D | ||
| 2023-01-23 | Exercise or conversion : show line 3 in the form | +519 | 6,519 | D | ||
| 2023-01-23 | Exercise or conversion : show line 4 in the form | +2,400 | 8,919 | D | ||
| 2023-01-23 | Sale : show line 5 in the form | −1,302 | $5.34 | $6,950 | 7,617 | D |
| 2023-01-24 | Sale : show line 6 in the form | −7 | $5.31 | $37 | 7,610 | D |
| Open-market sales · 1,309 sh · avg $5.34 · $6,988 | ||||||
Table II: Derivative
4 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-23 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −380 | 0 | D |
| 2023-01-23 | Exercise or conversion : show line 8 in the form Restricted Stock Units | −1,066 | 0 | D |
| 2023-01-23 | Exercise or conversion : show line 9 in the form Restricted Stock Units | −519 | 0 | D |
| 2023-01-23 | Exercise or conversion : show line 10 in the form Restricted Stock Units | −2,400 | 0 | D |
Loading xslF345X03/doc4.xml…